Paula Rochon

Dr. Paula Rochon is a Canadian geriatrician. She is notable in the COVID-19 pandemic due to her role on the Ontario COVID-19 Science Advisory Table.

In 1983, Rochon completed her MD at McMaster University. She received her Masters in Public Health from the Harvard School of Public Health in 1990.¹⁾

Rochon sits on the Editorial Board of the Journal of the American Geriatrics Society.²⁾

Rochon is an Adjunct Scientist at the Kunin-Lunenfeld Centre for Applied Research and Evaluation in Baycrest Health Sciences.^{3) 4)}

Rochon was elected as a fellow of the Canadian Academy of Health Sciences in 2013.⁵⁾

Rochon is the Vice-Chair of the Canadian Institutes of Health Research (CIHR) Institute of Aging Advisory Board.⁶⁾

Rochon is a member of the Long-Term Care and COVID-19 Expert Advisory Panel for the Government of Canada.⁷⁾

Rochon is a Senior Core Scientist at the Institute for Clinical Evaluative Sciences (ICES).^{8) 9)}

Rochon is a member of the Ontario COVID-19 Science Advisory Table and Chair of the Congregate Care Setting Working Group.¹⁰⁾

Rochon sits on the Editorial Board for the Drugs & Aging Journal published by Springer.¹¹⁾

Rochon received an Innovation Grant from the Peter Munk Cardiac Center at the University Health Network, for a research project called “Analytic approaches to understanding Covid-19 infections and outcomes in the population”.¹²⁾

Rochon is a professor in the Department of Medicine and Institute of Health Policy, Management and Evaluation of the Dalla Lana School of Public Health and is the inaugural Retired Teachers of Ontario Chair in Geriatric Medicine at the University of Toronto.^{13) 14)}

Rochon is a geriatrician, senior scientist and Vice-President of Research at Women’s College Hospital in Toronto, Ontario.^{15) 16) 17)} The WCH is funded through the Women's College Hospital Foundation by CIBC, KPMG. RBC (Royal Bank of Canada), Brookfield, Cadillac Fairview, Scotiabank, TD Bank Group, BMO Financial Group, Deloitte, PricewaterhouseCoopers, the University of Toronto, Allergan, Amgen, Bayer, Bell Canada, Credit Suisse, Fidelity, IBM, Goldman Sachs, the Government of Canada, HSBC, LifeLabs, Pacific Blue Cross, Morgan Stanley, National Bank, Shoppers Drug Mart, Thomson Reuters, Tribute Pharmaceuticals, BlackRock, Ontario Teachers' Pension Plan, State Street, TELUS, and others.¹⁸⁾

Dr. Rochon has a strong record of federal funding and has published more than 300 papers in peer-reviewed journals.

Rochon is part of a research group that received $409,179.00 from the Canadian Institutes of Health Research for a wide-ranging study labelled “Improving Canadian Outcomes Research On the Novel SARS-CoV-2 using Analytics: the CORONA Consortium”.¹⁹⁾

She is also participating in a study called “Finding the Right Balance? Implementing family presence policies in Ontario long-term care homes” funded by the CIHR and the Canadian Foundation for Healthcare Improvement.^{20) 21)}

• Career Award – Canadian Institutes of Health Research
• Dr. John Meyers Visiting Professor of Geriatric Medicine. University of Massachusetts Medical School
• Excellence in Leadership, Baycrest Rewards and Recognition Committee